TY - JOUR
T1 - Shaping the Infant Microbiome With Non-digestible Carbohydrates
AU - Verkhnyatskaya, Stella
AU - Ferrari, Michela
AU - de Vos, Paul
AU - Walvoort, Marthe T. C.
PY - 2019/2/25
Y1 - 2019/2/25
N2 - Natural polysaccharides with health benefits are characterized by a large structural diversity and differ in building blocks, linkages, and lengths. They contribute to human health by functioning as anti-adhesives preventing pathogen adhesion, stimulate immune maturation and gut barrier function, and serve as fermentable substrates for gut bacteria. Examples of such beneficial carbohydrates include the human milk oligosaccharides (HMOs). Also, specific non-digestible carbohydrates (NDCs), such as galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) are being produced with this purpose in mind, and are currently added to infant formula to stimulate the healthy development of the newborn. They mimic some functions of HMO, but not all. Therefore, many research efforts focus on identification and production of novel types of NDCs. In this review, we give an overview of the few NDCs currently available [GOS, FOS, polydextrose (PDX)], and outline the potential of alternative oligosaccharides, such as pectins, (arabino) xylo-oligosaccharides, and microbial exopolysaccharides (EPS). Moreover, state-of-the-art techniques to generate novel types of dietary glycans, including sialylated GOS (Sia-GOS) and galactosylated chitin, are presented as a way to obtain novel prebiotic NDCs that help shaping the infant microbiome.
AB - Natural polysaccharides with health benefits are characterized by a large structural diversity and differ in building blocks, linkages, and lengths. They contribute to human health by functioning as anti-adhesives preventing pathogen adhesion, stimulate immune maturation and gut barrier function, and serve as fermentable substrates for gut bacteria. Examples of such beneficial carbohydrates include the human milk oligosaccharides (HMOs). Also, specific non-digestible carbohydrates (NDCs), such as galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS) are being produced with this purpose in mind, and are currently added to infant formula to stimulate the healthy development of the newborn. They mimic some functions of HMO, but not all. Therefore, many research efforts focus on identification and production of novel types of NDCs. In this review, we give an overview of the few NDCs currently available [GOS, FOS, polydextrose (PDX)], and outline the potential of alternative oligosaccharides, such as pectins, (arabino) xylo-oligosaccharides, and microbial exopolysaccharides (EPS). Moreover, state-of-the-art techniques to generate novel types of dietary glycans, including sialylated GOS (Sia-GOS) and galactosylated chitin, are presented as a way to obtain novel prebiotic NDCs that help shaping the infant microbiome.
KW - infant
KW - microbiome
KW - non-digestible carbohydrates
KW - exopolysaccharides
KW - transglycosylation
KW - LACTIC-ACID BACTERIA
KW - HUMAN-MILK OLIGOSACCHARIDES
KW - MULTIENZYME OPME SYNTHESIS
KW - CROSS-FEEDING INTERACTIONS
KW - SUGAR-BEET PULP
KW - GALACTO-OLIGOSACCHARIDES
KW - NECROTIZING ENTEROCOLITIS
KW - ESCHERICHIA-COLI
KW - ENZYMATIC PRODUCTION
KW - GUT MICROBIOTA
U2 - 10.3389/fmicb.2019.00343
DO - 10.3389/fmicb.2019.00343
M3 - Review article
C2 - 30858844
VL - 10
JO - Frontiers in Microbiology
JF - Frontiers in Microbiology
SN - 1664-302X
M1 - 343
ER -